azacitidine has been researched along with Body Weight in 23 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 7 (30.43) | 18.7374 |
1990's | 7 (30.43) | 18.2507 |
2000's | 3 (13.04) | 29.6817 |
2010's | 6 (26.09) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bai, W; Gao, A; Niu, P; Tian, L; Yang, J; Zuo, X | 1 |
Chan, HL; Chen, YY; Chuang, JJ; Dai, YC; Lin, WH; Lin, YL; Liu, YW | 1 |
Dasgupta, C; Halavi, S; Hartman, RE; Li, Y; Ma, Q; Xiao, D; Zhang, L | 1 |
Li, K; Liang, J; Wu, Q; Zhang, J; Zhu, H | 1 |
Briggs, JE; Clouser, CL; Crankshaw, DL; Holtz, CM; Mansky, LM; Mullett, M; O'Sullivan, MG; Patterson, SE | 1 |
Jin, L; Piao, J; Yang, S; Zhou, Y | 1 |
Hatta, T; Matsumoto, A; Moriyama, K; Otani, H | 1 |
Anderson, LM; Branch, S; Cisneros, FJ; Travlos, G; Wilson, R | 1 |
Covey, JM; Zaharko, DS | 1 |
Asofsky, R; Hirschhorn, R; Kim, J; Ratech, H; Thorbecke, GJ | 1 |
Brunner, RL; Butcher, RE; Vorhees, CV | 1 |
Leone, VG; Londei, T; Mistò, R; Vismara, C | 1 |
Doerksen, T; Trasler, JM | 1 |
Erf, GF; Smyth, JR; Sreekumar, GP | 1 |
Hishinuma, T; Ishiwata, S; Mizugaki, M; Nose, M; Nozaki, S; Shindo, H; Yamaguchi, T | 1 |
Dietrich, A; Ehrlich, W; Grätz, R; Kröger, H; Wild, A | 1 |
Benoit, G; Doerksen, T; Trasler, JM | 1 |
Langman, J; Rodier, P; Webster, W | 1 |
Berger, AE; Bhuyan, BK; DeSante, DC; Neil, GL | 1 |
Reynolds, SS; Rodier, PM | 1 |
Ihara, T; Kurishita, A | 1 |
Csordas, A; Dietrich, H; Krömer, G; Schauenstein, K; Wick, G | 1 |
Gooderham, NJ; Mannering, GJ | 1 |
23 other study(ies) available for azacitidine and Body Weight
Article | Year |
---|---|
PTEN methylation involved in benzene-induced hematotoxicity.
Topics: Animals; Azacitidine; Benzene; Body Weight; Carcinogens; Cell Line, Tumor; Chemical and Drug Induced Liver Injury; DNA Methylation; Down-Regulation; Epigenesis, Genetic; Genes, Tumor Suppressor; Hydroxamic Acids; Leukocytes; Male; Promoter Regions, Genetic; PTEN Phosphohydrolase; Rats; Rats, Sprague-Dawley; RNA, Messenger; Up-Regulation | 2014 |
Downregulation of glutathione S-transferase M1 protein in N-butyl-N-(4-hydroxybutyl)nitrosamine-induced mouse bladder carcinogenesis.
Topics: Animals; Antimetabolites, Antineoplastic; Azacitidine; Blotting, Western; Body Weight; Butylhydroxybutylnitrosamine; Carcinogens; Cell Line, Tumor; Coloring Agents; Decitabine; Down-Regulation; Electrophoresis, Gel, Two-Dimensional; Female; Glutathione Transferase; Humans; Immunohistochemistry; Mice; Mice, Inbred C57BL; Mucous Membrane; Real-Time Polymerase Chain Reaction; RNA, Messenger; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Urinary Bladder; Urinary Bladder Neoplasms | 2014 |
Inhibition of DNA Methylation in the Developing Rat Brain Disrupts Sexually Dimorphic Neurobehavioral Phenotypes in Adulthood.
Topics: Aging; Animals; Animals, Newborn; Azacitidine; Behavior, Animal; Body Weight; Brain; Brain-Derived Neurotrophic Factor; Decitabine; DNA (Cytosine-5-)-Methyltransferase 1; DNA Methylation; Female; Male; Maze Learning; Organ Size; Phenotype; Promoter Regions, Genetic; Rats, Sprague-Dawley; Receptor, trkB; RNA, Messenger; Rotarod Performance Test; Sex Characteristics | 2017 |
Changes in the levels of DNA methylation in testis and liver of SD rats neonatally exposed to 5-aza-2'-deoxycytidine and cadmium.
Topics: Animals; Animals, Newborn; Antimetabolites, Antineoplastic; Apoptosis; Azacitidine; Base Sequence; Body Weight; Cadmium Chloride; Decitabine; DNA (Cytosine-5-)-Methyltransferase 1; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; Drug Therapy, Combination; Enzyme Inhibitors; Female; Liver; Male; Molecular Sequence Data; Organ Size; Promoter Regions, Genetic; Rats; Rats, Sprague-Dawley; Sperm Count; Testis; Tumor Suppressor Protein p53 | 2011 |
Activity of a novel combined antiretroviral therapy of gemcitabine and decitabine in a mouse model for HIV-1.
Topics: Animals; Anti-HIV Agents; Azacitidine; Body Weight; Cells, Cultured; Chemical and Drug Induced Liver Injury; Decitabine; Deoxycytidine; Drug Combinations; Drug Synergism; Female; Flow Cytometry; Gemcitabine; HIV-1; Humans; Liver; Lymph Nodes; Mice; Mice, Inbred C57BL; Murine Acquired Immunodeficiency Syndrome; Proviruses; Spleen; T-Lymphocytes; Transfection | 2012 |
Does pretreatment of bone marrow mesenchymal stem cells with 5-azacytidine or double intravenous infusion improve their therapeutic potential for dilated cardiomyopathy?
Topics: Animals; Azacitidine; Body Weight; Bone Marrow Cells; Bromodeoxyuridine; Cardiomyopathy, Dilated; Cell Transdifferentiation; Collagen; Female; Fibrosis; Gene Expression Regulation; Heart Function Tests; Infusions, Intravenous; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Myocardium; Natriuretic Peptide, Brain; Rats; Rats, Wistar; RNA, Messenger; Survival Analysis; Troponin T; Vascular Endothelial Growth Factor A | 2013 |
Opposite effects of the maternal immune system activated by interleukin-1beta vs. PSK and OK432 on 5-azacytidine-induced birth defects.
Topics: Abnormalities, Multiple; Adjuvants, Immunologic; Animals; Antimetabolites, Antineoplastic; Antineoplastic Agents; Azacitidine; Body Weight; Brain; Congenital Abnormalities; Female; Interleukin-1; Mice; Mice, Inbred ICR; Microscopy, Electron, Scanning; Phagocytes; Picibanil; Placenta; Pregnancy; Pregnancy, Animal; Proteoglycans; Teratogens; Time Factors | 2003 |
Susceptibility to postnatal growth retardation induced by 5-AZA-2'-deoxycytidine in utero: gender specificity and correlation with reduced insulin-like growth factor 1.
Topics: Animals; Antimetabolites, Antineoplastic; Azacitidine; Blood Glucose; Body Weight; Corticosterone; Decitabine; Depression, Chemical; Energy Metabolism; Female; Growth Disorders; Insulin-Like Growth Factor I; Mice; Pregnancy; Sex Characteristics | 2003 |
Effects of 5-aza-2'-deoxycytidine in combination with the biochemical modulator thymidine or the immune modulator pyran copolymer on L1210 leukemia-bearing mice.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Azacitidine; Body Weight; Decitabine; Leukemia L1210; Male; Mice; Polymers; Pyran Copolymer; Thymidine; Time Factors | 1984 |
Effects of deoxycoformycin in mice. II. Differences between the drug sensitivities and purine metabolizing enzymes of transplantable lymphomas of varying immunologic phenotypes.
Topics: Adenosine Deaminase; Animals; Azacitidine; Body Weight; Coformycin; Deoxyadenosines; DNA; Lymphoma; Mice; Mice, Inbred AKR; Mice, Inbred BALB C; Neoplasm Transplantation; Nucleoside Deaminases; Organ Size; Pentostatin; Phenotype; Ribonucleosides; Spleen; T-Lymphocytes; Thymus Gland | 1984 |
Developmental toxicity and psychotoxicity of potassium iodide in rats: a case for the inclusion of behaviour in toxicological assessment.
Topics: Administration, Oral; Animals; Azacitidine; Body Weight; Female; Fetal Death; Injections, Intraperitoneal; Litter Size; Male; Maternal-Fetal Exchange; Motor Activity; Organ Size; Potassium Iodide; Pregnancy; Rats; Rats, Inbred Strains; Reflex, Startle | 1984 |
Congenital brain damage spares the basic patterns of parental behavior in affected mice.
Topics: Animals; Azacitidine; Body Weight; Brain; Brain Damage, Chronic; Cannibalism; Female; Male; Maternal Behavior; Mice; Motor Activity; Nesting Behavior; Paternal Behavior; Pregnancy; Reproduction | 1995 |
Developmental exposure of male germ cells to 5-azacytidine results in abnormal preimplantation development in rats.
Topics: Animals; Azacitidine; Body Weight; Embryonic Development; Erythrocyte Count; Female; Fetal Death; Leukocyte Count; Male; Organ Size; Pregnancy; Rats; Rats, Sprague-Dawley; Sperm Count; Spermatozoa; Spleen; Testis | 1996 |
5-azacytidine treatment induces autoimmune vitiligo in parental control strains of the Smyth line chicken model for autoimmune vitiligo.
Topics: Animals; Autoimmune Diseases; Azacitidine; Body Weight; Chickens; Disease Models, Animal; Erythrocyte Count; Feathers; Incidence; Leukocyte Count; Lymphocyte Activation; Lymphoid Tissue; Organ Size; Vitiligo | 1996 |
Alteration of DNA methylation levels in MRL lupus mice.
Topics: Animals; Azacitidine; Body Weight; DNA; DNA Methylation; Lupus Erythematosus, Systemic; Mice; Mice, Inbred MRL lpr; Organ Size | 1997 |
The effect of tryptophan plus methionine, 5-azacytidine, and methotrexate on adjuvant arthritis of rat.
Topics: Animals; Antirheumatic Agents; Arthritis, Experimental; Azacitidine; Body Weight; Drug Therapy, Combination; Freund's Adjuvant; Male; Methionine; Methotrexate; Rats; Tryptophan | 1999 |
Deoxyribonucleic acid hypomethylation of male germ cells by mitotic and meiotic exposure to 5-azacytidine is associated with altered testicular histology.
Topics: Animals; Apoptosis; Azacitidine; Blotting, Western; Body Weight; Cell Separation; Cytosine; DNA; DNA Methylation; Female; Germ Cells; Male; Meiosis; Mitosis; Pregnancy; Pregnancy Outcome; Proteins; Rats; Rats, Sprague-Dawley; Spermatocytes; Spermatogonia; Testis | 2000 |
Interference with proliferative activity in the CNS and its relation to facial abnormalities.
Topics: Abnormalities, Drug-Induced; Animals; Azacitidine; Behavior, Animal; Body Weight; Brain; Cell Differentiation; Cell Division; Central Nervous System; Face; Female; Mice; Organ Size | 1975 |
Combination chemotherapy of L1210 leukemia with 1-beta-D-arabinofuranosylcytosine and 5-azacytidine.
Topics: Animals; Azacitidine; Body Weight; Cells, Cultured; DNA Replication; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Leukemia L1210; Mice | 1976 |
Morphological correlates of behavioral abnormalities in experimental congenital brain damage.
Topics: Animals; Azacitidine; Body Weight; Brain; Brain Damage, Chronic; Cerebral Cortex; Female; Frontal Lobe; Gestational Age; Hippocampus; Male; Mice; Movement Disorders; Organ Size; Pregnancy; Pyramidal Tracts; Septum Pellucidum | 1977 |
Inhibitory effects of cobalt chloride and cinnamaldehyde on 5-azacytidine-induced digital malformations in rats.
Topics: Abnormalities, Drug-Induced; Acrolein; Aldehydes; Analysis of Variance; Animals; Azacitidine; Body Weight; Cobalt; Female; Fetal Death; Humans; Pregnancy; Rats; Rats, Inbred Strains; Toes | 1990 |
In-vivo treatment with 5-azacytidine causes degeneration of central lymphatic organs and induces autoimmune disease in the chicken.
Topics: Animals; Autoimmune Diseases; Azacitidine; Body Weight; Bone Marrow; Chickens; Lymphatic Diseases; Lymphoid Tissue; Organ Size; Organ Specificity | 1991 |
Depression of the hepatic cytochrome P-450 monooxygenase system by treatment of mice with the antineoplastic agent 5-azacytidine.
Topics: Animals; Azacitidine; Body Weight; Cytochrome b Group; Cytochrome P-450 Enzyme System; Cytochromes b5; Electron Transport; Ethylmorphine-N-Demethylase; Hexobarbital; In Vitro Techniques; Interferons; Liver; Male; Mice; Organ Size; Oxygenases; Rats; Rats, Inbred Strains; Sleep | 1985 |